Cover Image
Market Research Report
Product code 
985570

Global Opioids Drug Market, Size, Share, Opportunities and Forecast, 2020-2027

Published: | DataM Intelligence | 180 Pages | Delivery time: 2 business days

Price

Back to Top
Global Opioids Drug Market, Size, Share, Opportunities and Forecast, 2020-2027
Published: April 3, 2021
DataM Intelligence
Content info: 180 Pages
Delivery time: 2 business days
  • ALL
  • Description
  • Table of Contents
Description

Global Opioids Drug Market is segmented By Product (Buprenorphine, Fentanyl, Hydrocodone, Morphine, Oxycodone, Others), By Application (Pain Relief, Anesthesia, Cough Suppression, Diarrhea Suppression, Deaddiction), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Share, Size, Outlook, and Opportunity Analysis, 2020-2027

Market Overview

The Global Opioids Drug Market is expected to grow at a CAGR of 3.3% during the forecasting period (2020-2027).

Opioids are a class of drugs naturally found in the opium poppy plant and work in the brain to produce various effects, including pain relief with many of these drugs. Opioids can be prescription medications often referred to as painkillers or so-called street drugs, such as heroin. Many prescription opioids are used to block pain signals between the brain and the body and are typically prescribed to treat moderate to severe pain.

Source: DataM Intelligence Analysis (2019)

Market Dynamics:

The key drivers contributing to the global opioids drug market's growth are escalating palliative care for patients suffering intensely and using abuse-deterrent preparations to restrict opioid abuse. Moreover, the increasing prevalence of diseases that cause chronic pain, such as post-surgical pain, cancer, fibromyalgia, lower back pain, and arthritis, drives the market.

The growing prevalence of cancer leads to the market's growth.

The rising number of medical cases and the growing prevalence of cancer are considered major factors driving the market's growth worldwide. Opioids are narcotic drugs recommended for the management of moderate to severe pain in cancer treatment. The American Cancer Society explicates that opioids play a critical role in relieving pain due to this disease and curing cancer patients. Therefore, with the considerable increase in cancer prevalence globally, the demand for prescription opioid drugs is also expected to rise during the forecast period.

The rising number of lawsuits for opioids may hinder the market growth.

The increasing number of lawsuits against opioid manufacturers and the rising incidence of fatalities related to opioid overdose are major factors that impede the opioids drug market growth. The increasing opioid crisis has led to the filing of lawsuits instead of pharmaceuticals companies engaged in manufacturing opioid drugs. The lawsuits are filed against the companies alleging that the drug manufacturers hid data of the addiction after-effects of opioid drugs. The number of deaths due to drug overdose is increasing greatly, and opioids contribute significantly to such health issues. The opioid addiction and growing trend of opioid abuse are the major factors contributing to the high death rate related to opioid overdose.

COVID-19 Impact Analysis

The COVID-19 pandemic is expected to derail the growth of the opioids drug market in 2020. Since establishing new guidelines for the usage and manufacturing of opioids and the major focus of the research institutes on developing a vaccine for COVID-19, the study on opioids drugs has halted, hampering the market growth. Moreover, the diagnosis of new cancer cases decreased during the pandemic, which impacted the market value of opioids drugs in 2020.   

Segment Analysis

The opioids drug market is classified into pain relief, anesthesia, cough suppression, diarrhea suppression, and deaddiction by an application.

Pain relief leads the opioids drug market globally.

The pain relief segment dominated the opioids drug market in 2019, backed by its elevated usage in pain management therapies. The use of opioids drugs for pain is expected to decline during the forecast period due to the new regulatory framework's enactment. The guideline has been devised by the CDC (Centers for Disease Control and Prevention) for prescribing opioids for chronic pain. According to the guideline, it has been advised that non-opioid therapy should be chosen for chronic pain other than end-of-life care, palliative, and active cancer.

By product, the opioids drug market is classified into buprenorphine, fentanyl, hydrocodone, morphine, oxycodone, and others.

Buprenorphine segment to dominate global opioids drug market.

Buprenorphine is anticipated to project the fastest growth in the market. This opioid has strong responsiveness to the opioid receptor. It is a byproduct of the opioid alkaloid and is more effective as compared to morphine. Buprenorphine acts as a part agonist at mu and kappa opioid receptors and functions as an antagonist at delta receptors. Several federal initiatives are expected to increase the treatment approach for opioid use disorder, which is expected to create prospects for the strong growth of the buprenorphine market during the forecast period.

Source: DataM Intelligence Analysis (2019)

Geographical Analysis

North America dominated the global market throughout the forecast period.

North America contributed the major share in the global opioids drug market in 2019. The well-developed healthcare infrastructure in the U.S. and several healthcare research centers drive the region's growth. However, the US is likely to witness a decline in its market growth during the forecast period, backed by the rising government initiatives to tackle the country's crisis. In June 2018, the Government of the U.S. launched a public awareness advertising campaign to fight against addiction. Besides, a few of the opioid products, including Purdue Pharma' OxyContin, have been discontinued in the U.S. and Canada.

Moreover, the Asia Pacific region is expected to project the highest CAGR globally during the forecast period. Most Asian-Pacific economies suffer from a stigma related to the addiction associated with opioids among patients and physicians. To tackle this growing stigma, the Government of China launched a 'good pain management' program in the year 2011, which targets regulating cancer pain treatment, thereby improving the quality of cancer patients' lives. Moreover, companies such as Purdue Pharma shift their focus towards this region, intending to strengthen their market position.

Competitive Landscape

The opioids drug market is dominating by a few companies. Some of the key players in the market's growth include Purdue Pharma L.P., Sun Pharmaceutical Industries Limited, Allergan PLC, and Pfizer Inc. The key players execute several growth strategies such as product launches, acquisitions, and collaborations, which are estimated to boost the opioids drug market growth globally.  

Sun Pharmaceutical Industries Limited

Overview: Sun Pharmaceuticals Industries Limited is an Indian multinational company established in 1983 and is headquartered in Mumbai. It is focused on producing and distributing pharmaceutical products that can cater to the people suffering from the problem. The revenue generated by the company FY 18-2019 was $4.4 billion. The subsidiaries of the Sun pharmaceuticals are Ranbaxy, Pharmalucence, Insite Vision. The company's product portfolio is segmented into formulations, API, and Over Table (OTC) drugs.

Product Type Portfolio: The company's portfolio comprised Methadone.

Why Purchase the Report?

Visualize the composition of the opioids drug market segmentation by product, application, and region, highlighting the key commercial assets and players.

Identify commercial opportunities in the opioids drug market by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of opioids drug market - level 2 segmentation.

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Product mapping in excel for the key product of all major market players

The global opioids drug market report would provide approximately 51 market data tables, 49 figures, and 268 pages.

Target Audience

Service Providers/ Buyers

Industry Investors/Investment Bankers

Education & Research Institutes

Research Professionals

Emerging Companies

Manufacturers

Related Topic's

Imatinib Drug Market

AMD Drugs Market

Generic Drugs Market

Table of Contents

Table of Contents

Table of Contents

Opioids Drug Market Methodology and Scope

Research Methodology

Research Objective and Scope of the Report

Opioids Drug Market - Market Definition and Overview

Opioids Drug Market - Executive Summary

Market Snippet by Product

Market Snippet by Application

Market Snippet by Region

Opioids Drug Market-Market Dynamics

Market Impacting Factors

Drivers

Increasing prevalence of cancer globally

Growing palliative care for intensely suffering patients

Medicines

Restraints:

Lawsuits against opioids drug manufacturers

Opportunity

Impact Analysis

Opioids Drug Market - Industry Analysis

Porter's Five Forces Analysis

Supply Chain Analysis

Value Chain Analysis

PEST Analysis

Pricing Analysis

Regulatory Analysis

Reimbursement Analysis

Unmet Needs

Patent Trends

Opioids Drug Market - COVID-19 Analysis

Analysis of Covid-19 on the Market

Before COVID-19 Market Scenario

Present COVID-19 Market Scenario

After COVID-19 or Future Scenario

Pricing Dynamics Amid Covid-19

Demand-Supply Spectrum

Government Initiatives Related to the Market During Pandemic

Manufacturers Strategic Initiatives

Conclusion 

Opioids Drug Market - By Product

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Segment

Market Attractiveness Index, By Product Segment

Buprenorphine

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%)

Fentanyl

Hydrocodone

Morphine

Oxycodone

Others

Opioids Drug Market - By Application

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment

Market Attractiveness Index, By Application Segment

Pain Relief

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%)

Anesthesia

Cough Suppression

Diarrhea Suppression

Deaddiction

Opioids Drug Market - By Region

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region

Market Attractiveness Index, By Region

North America

Introduction

Key Region-Specific Dynamics

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

The U.S.

Canada

Mexico

Europe

Introduction

Key Region-Specific Dynamics

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

Germany

The U.K.

France

Italy

Spain

Rest of Europe

South America

Introduction

Key Region-Specific Dynamics

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

Brazil

Argentina

Rest of South America

Asia Pacific

Introduction

Key Region-Specific Dynamics

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

China

India

Japan

Australia

Rest of Asia Pacific

The Middle East and Africa

Introduction

Key Region-Specific Dynamics

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

Opioids Drug Market - Competitive Landscape

Competitive Scenario

Market Positioning/Share Analysis

Mergers and Acquisitions Analysis

Opioids Drug Market- Company Profiles

Purdue Pharma L.P.*

Company Overview

Product Portfolio and Description

Key Highlights

Financial Overview

Janssen Pharmaceuticals, Inc.

West-Ward Pharmaceuticals Corporation

Pfizer Inc.

Cipher Pharmaceuticals Inc.

Lupin Ltd.

Allergan PLC

Sanofi-Aventis S.A.

Sun Pharmaceutical Industries Limited

Grunenthal GmbH

China Aoxing Pharmaceutical Company, Inc.

Other Companies

Opioids Drug Market - Premium Insights

Opioids Drug Market - DataM Intelligence

Appendix

About Us and Services

Contact Us

Suggestions for Related Market Report:

Opioid Use Disorder Market

Therapeutic Drug Monitoring Market

Non-Opioid Pain Treatment Market

Cancer Supportive Care Drugs Market